Investigative Tools
Panel 3
Background Resources
Research Letter
Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications with the US FDA (JAMA)
Research Letter
Effect of US Drug Enforcement Administration’s Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing (JAMA)
Commentary
Suggestions for Improving Conflict of Interest Processes in the US FDA Advisory Committees — Past Imperfect (JAMA)
Article
Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries (NEJM)
Speaker Presentations
Presentation link: The ins and outs of advocacy
